CareMax (CMAX)
(Real Time Quote from BATS)
$1.80 USD
-0.08 (-4.26%)
Updated Sep 24, 2024 01:40 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Income Statements
Fiscal Year end for CareMax, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 751 | 631 | 296 | 0 | NA |
Cost Of Goods | 737 | 551 | 264 | 0 | NA |
Gross Profit | 14 | 80 | 31 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 670 | 192 | 60 | 4 | 0 |
Income After Depreciation & Amortization | -656 | -112 | -29 | -4 | 0 |
Non-Operating Income | 26 | 75 | 22 | -18 | NA |
Interest Expense | 54 | 20 | 0 | 0 | NA |
Pretax Income | -684 | -57 | -7 | -4 | NA |
Income Taxes | -1 | -20 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -683 | -38 | -7 | -4 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -683 | -38 | -7 | -4 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -73 | -18 | -15 | -4 | 0 |
Depreciation & Amortization (Cash Flow) | 583 | 94 | 14 | 0 | NA |
Income After Depreciation & Amortization | -656 | -112 | -29 | -4 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3.73 | 3.02 | 1.75 | NA | NA |
Diluted EPS Before Non-Recurring Items | -41.98 | -20.42 | -3.90 | NA | NA |
Diluted Net EPS (GAAP) | -183.31 | -12.61 | -3.90 | -6.61 | NA |
Fiscal Year end for CareMax, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 198.63 | 232.25 | 151.84 | 201.84 | 224.44 |
Cost Of Goods | 195.71 | 224.07 | 207.75 | 182.97 | 197.19 |
Gross Profit | 2.92 | 8.17 | -55.91 | 18.88 | 27.25 |
SG&A, R&D, and Dept/Amort Expenses | 155.66 | 29.88 | 397.09 | 109.65 | 31.01 |
Income After SG&A, R&D, and Dept/Amort Expenses | -152.74 | -21.71 | -453.00 | -90.77 | -3.76 |
Non-Operating Income | 2.74 | -1.77 | 2.62 | 1.83 | -15.25 |
Interest Expense | 20.38 | 19.76 | 16.78 | 14.00 | 13.20 |
Pretax Income | -170.38 | -43.23 | -467.16 | -102.95 | -32.20 |
Income Taxes | 0.18 | 0.18 | -1.39 | 0.18 | 0.18 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -170.56 | -43.41 | -465.77 | -103.12 | -32.38 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -170.56 | -43.41 | -465.77 | -103.12 | -32.38 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 3.81 | 3.78 | 3.74 | 3.73 | 3.72 |
Diluted EPS Before Non-Recurring Items | -10.48 | -10.99 | -25.82 | -6.31 | -4.50 |
Diluted Net EPS (GAAP) | -44.79 | -11.49 | -124.75 | -27.63 | -8.71 |